Although hepatic mRNA expressions of CX26, CX32, and CX43 remain unchanged during the development of NAFLD and diabetes, they may still play significant roles in maintaining metabolic homeostasis by providing constitutive ATP release. The gene discussed is GJB2; the disease is metabolic dysfunction-associated steatotic liver disease.